DK2095128T3 - Fremgangsmåde til differentieret diagnosticering af demens - Google Patents

Fremgangsmåde til differentieret diagnosticering af demens

Info

Publication number
DK2095128T3
DK2095128T3 DK07846655.4T DK07846655T DK2095128T3 DK 2095128 T3 DK2095128 T3 DK 2095128T3 DK 07846655 T DK07846655 T DK 07846655T DK 2095128 T3 DK2095128 T3 DK 2095128T3
Authority
DK
Denmark
Prior art keywords
dementia
differential diagnosis
diagnosis
differential
Prior art date
Application number
DK07846655.4T
Other languages
English (en)
Inventor
Mirko Bibl
Brit Mollenhauer
Jens Wiltfang
Hermann Esselmann
Piotr Lewczuk
Johannes Kornhuber
Original Assignee
Univ Friedrich Alexander Er
Univ Goettingen Georg August
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06023954A external-priority patent/EP1923704A1/en
Application filed by Univ Friedrich Alexander Er, Univ Goettingen Georg August filed Critical Univ Friedrich Alexander Er
Application granted granted Critical
Publication of DK2095128T3 publication Critical patent/DK2095128T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2871—Cerebrovascular disorders, e.g. stroke, cerebral infarct, cerebral haemorrhage, transient ischemic event

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
DK07846655.4T 2006-11-17 2007-11-19 Fremgangsmåde til differentieret diagnosticering af demens DK2095128T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06023954A EP1923704A1 (en) 2006-11-17 2006-11-17 Method of diagnosing vascular dementias and acute cerebral ischemia
EP06025097 2006-12-05
PCT/EP2007/009974 WO2008058760A1 (en) 2006-11-17 2007-11-19 Method of differentially diagnosing dementias

Publications (1)

Publication Number Publication Date
DK2095128T3 true DK2095128T3 (da) 2013-12-16

Family

ID=39029115

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07846655.4T DK2095128T3 (da) 2006-11-17 2007-11-19 Fremgangsmåde til differentieret diagnosticering af demens

Country Status (8)

Country Link
US (1) US20090239311A1 (da)
EP (2) EP2095128B1 (da)
JP (2) JP5445844B2 (da)
AU (1) AU2007321841B2 (da)
CA (1) CA2669848A1 (da)
DK (1) DK2095128T3 (da)
ES (2) ES2441253T3 (da)
WO (1) WO2008058760A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011529185A (ja) * 2008-07-25 2011-12-01 メルク・シャープ・エンド・ドーム・コーポレイション アルツハイマー病患者の認知低下を予測するためのｃｓｆバイオマーカー
WO2011133583A1 (en) * 2010-04-19 2011-10-27 Functional Neuromodulation Inc. Deep brain stimulation of memory circuits in alzheimer's disease
EP4040157A1 (en) * 2014-05-22 2022-08-10 Shimadzu Corporation Surrogate biomarker for evaluating intracerebral amyloid beta peptide accumulation and method for analysis thereof
EP4424704A3 (en) * 2015-09-16 2024-12-25 Shimadzu Corporation Multiplex biomarker for use in evaluation of state of accumulation of amyloid b in brain, and analysis method for said evaluation
BR112021000895A2 (pt) * 2018-07-19 2021-04-13 Genentech, Inc. Métodos para identificar um indivíduo como possuindo ou estando em risco de desenvolver uma demência positiva para amilóide e para detectar um indivíduo com um valor aumentado para uma combinação de marcadores e uso de ass40, ass42 e ttau
WO2020261608A1 (ja) * 2019-06-28 2020-12-30 株式会社島津製作所 アミロイドβの脳内蓄積状態評価方法及び評価装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE312349T1 (de) * 1998-07-03 2005-12-15 Innogenetics Nv Differentielle diagnose von neurodegeneration
ES2228697T3 (es) * 2001-06-12 2005-04-16 Wiltfang, Jens Anticuerpo monoclonal, mab 1e8, que es especifico para los dos primeros aminoacidos de peptidos beta-amiloides y su utilizacion en la deteccion de peptidos beta-amiloides y/o sapp alfa.
AU2003253014A1 (en) * 2002-06-21 2004-01-06 Innogenetics N.V. Method for the diagnosis and differential diagnosis of neurological diseases
EP1480041A1 (en) * 2003-05-22 2004-11-24 Innogenetics N.V. Method for the prediction, diagnosis and differential diagnosis of Alzheimer's disease
JP2008519988A (ja) * 2004-11-12 2008-06-12 ファイザー・インク アミロイド−ベータペプチドを測定する方法
ATE523788T1 (de) * 2006-06-08 2011-09-15 Fu Berlin ASSAY ZUR DIAGNOSE VON ALZHEIMER BASIEREND AUF DER BESTIMMUNG DES VERHÄLTNISSES VON SEKRETASE-Aß-SPALTPRODUKTEN

Also Published As

Publication number Publication date
AU2007321841A1 (en) 2008-05-22
JP5904418B2 (ja) 2016-04-13
ES2535978T3 (es) 2015-05-19
EP2095128B1 (en) 2013-10-02
EP2437067A2 (en) 2012-04-04
CA2669848A1 (en) 2008-05-22
WO2008058760A1 (en) 2008-05-22
JP2010520988A (ja) 2010-06-17
EP2437067A3 (en) 2012-11-07
JP2014095714A (ja) 2014-05-22
ES2441253T3 (es) 2014-02-03
AU2007321841B2 (en) 2013-07-04
JP5445844B2 (ja) 2014-03-19
US20090239311A1 (en) 2009-09-24
EP2095128A1 (en) 2009-09-02
EP2437067B1 (en) 2015-03-18

Similar Documents

Publication Publication Date Title
NO347009B1 (no) Beregning av differansen mellom seismiske avbildninger innsamlet til forskjellige tider
DK2126801T3 (da) Fremgangsmåde til udvælgelse af information
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
BRPI0814804A2 (pt) Método de intensificar recuperação de óleo
DK2046767T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK2004794T3 (da) Fremgangsmåde til mæskning
DK2054711T3 (da) Fremgangsmåde til fremstilling af mikroarrays
DK1966393T3 (da) Fremgangsmåde til AFLP-baseret påvisning af polymorfisme med høj omsætning
DK2081669T3 (da) Fremgangsmåde og anordning til fremstilling af granulater
DK2024504T4 (da) Fremstilling af isoprenoider
DK2072600T3 (da) Fremgangsmåde til at forbedre jord
DK1893586T3 (da) Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler
DK3106873T3 (da) Fremgangsmåde til detektering af cancer
DE112007002964A5 (de) Differentialgetriebe
DK1884507T3 (da) Fremgangsmåde til fremstilling af glycerol
DK2076330T3 (da) Fremgangsmåde til fremstilling af katalysatorer
NO20083328L (no) Fremgangsmåte for fremstilling av papir
DK3214083T3 (da) Fremgangsmåde til fremstilling af quinolonforbindelser
DK2029567T3 (da) Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater
DK2061746T3 (da) Fremgangsmåde til fremstilling af diestere
DK2079843T3 (da) Fremgangsmåde til fremstilling af biogas
BRPI0718145A2 (pt) Método de micronização
DK1912476T3 (da) Fremgangsmåde til træning af høreevne
DK2080811T3 (da) Fremgangsmåde til evaluering af DNA-integriteten af mikroorganismer
DK2077913T3 (da) Fremgangsmåde til regenerering af filterhjælpemiddel